JOHNSON KENNETH ERLAND 4
4 · Xeris Biopharma Holdings, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
JOHNSON KENNETH ERLAND
See Remarks
Transactions
- Award
Common Stock
2024-01-31+175,000→ 446,860 total
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit award under the Company's 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock. These shares shall vest in equal annual installments over three years.
- [F2]These shares include 2,077 shares that were purchased on June 30, 2023 due to participation by the reporting individual in the issuer's 2018 Employee Stock Purchase Plan.